Physiomics plc (AIM: PYC), a leading mathematical modelling, data science and biostatistics company supporting the development of new therapeutics and personalised medicine solutions, is pleased to announce a sizeable contract extension award with an existing large pharma client. The project builds upon the contract award announced on 13 June 2024, where the Company’s proprietary Virtual Tumour platform has been used to model the client’s targeted oncology...
Read More